Shandong Weigao Group Medical Polymer Company Limited

HKSE 1066.HK

Shandong Weigao Group Medical Polymer Company Limited Receivables for the year ending December 31, 2023: USD 0.00

Shandong Weigao Group Medical Polymer Company Limited Receivables is USD 0.00 for the year ending December 31, 2023, a -100.00% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Shandong Weigao Group Medical Polymer Company Limited Receivables for the year ending December 31, 2022 was USD 831.09 M, a 1.73% change year over year.
  • Shandong Weigao Group Medical Polymer Company Limited Receivables for the year ending December 31, 2021 was USD 816.98 M, a 4.50% change year over year.
  • Shandong Weigao Group Medical Polymer Company Limited Receivables for the year ending December 31, 2020 was USD 781.77 M, a 25.39% change year over year.
  • Shandong Weigao Group Medical Polymer Company Limited Receivables for the year ending December 31, 2019 was USD 623.48 M, a 9.73% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
HKSE: 1066.HK

Shandong Weigao Group Medical Polymer Company Limited

CEO Mr. Rinan Cong
IPO Date Feb. 27, 2004
Location China
Headquarters Torch Hi-Tech Science Park
Employees 12,606
Sector Health Care
Industries
Description

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Similar companies

0853.HK

MicroPort Scientific Corporation

USD 0.69

2.27%

2607.HK

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.58

1.46%

1099.HK

Sinopharm Group Co. Ltd.

USD 2.59

1.33%

0867.HK

China Medical System Holdings Limited

USD 0.91

-0.72%

StockViz Staff

January 15, 2025

Any question? Send us an email